Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHVF)

266.99
Delayed Data
As of May 27
 +11.98 / +4.70%
Today’s Change
238.95
Today|||52-Week Range
308.91
-2.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$187.6B

Company Description

Roche Holding AG operates as a research healthcare company. It operates through the diagnostics and pharmaceuticals segments. The pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Contact Information

Roche Holding AG
Grenzacherstrasse 124
Basel Basel-stadt (basle Town) 4070
P:(161) 688-1111
Investor Relations:
(416) 168-8389

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Severin SchwanChief Executive Officer & Executive Director
Roland DiggelmannCOO-Roche Diagnostics Division
Daniel O'DayCOO-Roche Pharmaceuticals Division
Alan HippeChief Financial & Information Technology Officer
Urs JaisliChief Compliance Officer